N P Peet
N P Peet
M A Morse
M A Morse
The expansion of human stem cells and their genetic manipulation represent areas of increasing interest in the field of stem cell transplantation. Previously, stem cell transplantation has been accomplished by using cellular products obtain...
A W Griffioen
A W Griffioen
Agouron Pharmaceuticals is developing AG-3340 (prinomastat), the lead compound in a series of structurally related metalloproteinase inhibitors, for the potential treatment of cancer and age-related macular degeneration. AG-3340, an oral, n...
Atiprimod (AnorMED) [0.03%]
阿提普利莫(安诺瑞克)
D B Lakings
D B Lakings
Atiprimod is a macrophage-targeting oral cytokine inhibitor which is being developed by AnorMED as a potential treatment for rheumatoid arthritis and other autoimmune diseases. Phase I trials have been successfully completed and phase II mu...
Glycine antagonists for the treatment of stroke: a literature survey (1997-1999) [0.03%]
甘氨酸拮抗剂治疗卒中的研究(1997-1999)
F Michelli,A Pasquarello
F Michelli
A Bell
A Bell
Malaria remains a major infectious disease and is worsening in some areas, partly because of the spread of resistance to established antimalarial drugs. New drugs are urgently needed to combat the protozoan parasite, Plasmodium. This review...